[Chronic obstructive pulmonary disease (COPD) in the elderly].
Chronic obstructive pulmonary disease (COPD) is a chronic disease characterized by incompletely reversible airflow limitation, measured by a decrease of FEV(1)/FVC ratio. International consensus does not agree on a single threshold for this ratio, which can define airflow obstruction. Although the prevalence of COPD in the elderly population varies according to the definition used, it definitely increases with age and could reach 15% in those over 65 years of age. Therefore, ageing of the population should result in increased prevalence and socioeconomical costs of COPD during coming years. In France, diagnosis of COPD in the elderly is difficult, late and insufficient. Management, which has the same goals as in younger populations, has to be global and coordinated. Some points should be considered with particular attention considering the cumulative risks related on the one hand to COPD and on the other to ageing: pharmacological side-effects, decreased physical and social autonomy, nutritional impairment, comorbidities. Given the lack of specific data in elderly populations, pharmacological indications are generally considered to be the same as in younger populations, but some additional precautionary measures are necessary. Pulmonary rehabilitation seems to be beneficial at any age. Palliative care comes up against important difficulties: an indefinite beginning of the palliative stage in COPD; insufficient palliative care resources; insufficient communication; insufficient utilization of palliative care resources. Global COPD management in elderly requires coordination, best reached in health care network organizations involving medical and/or social professionals.
Orvoen-Frija
E
E
Service de physiologie, hôpital de la Pitié-Salpêtrière, CHU, 47-83, boulevard de l'Hôpital, 75181 Paris cedex 3, France. elisabeth.frija-orvoen@psl.aphp.fr
Benoit
M
M
Catto
M
M
Chambouleyron
M
M
Duguet
A
A
Emeriau
J-P
JP
Ferry
M
M
Hayot
M
M
Jeandel
C
C
Morize
V
V
Nassih
K
K
Ouksel
H
H
Piette
F
F
Prefaut
C
C
Roche
N
N
de Wazieres
B
B
Zureik
M
M
D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D002318:Cardiovascular Diseases / Q000453:epidemiology; D019090:Case Management; D015897:Comorbidity; D003863:Depression / Q000453:epidemiology / Q000209:etiology; D004347:Drug Interactions; D005602:France / Q000453:epidemiology; D006801:Humans; D044342:Malnutrition / Q000453:epidemiology / Q000517:prevention & control; D010166:Palliative Care; D010348:Patient Care Team; D010353:Patient Education as Topic; D015995:Prevalence; D029424:Pulmonary Disease, Chronic Obstructive / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000523:psychology / Q000534:rehabilitation; D019141:Respiratory System Agents / Q000009:adverse effects / Q000627:therapeutic use; D012306:Risk
D019141:Respiratory System Agents